Incidental Mutation 'R0085:Tab1'
ID 19870
Institutional Source Beutler Lab
Gene Symbol Tab1
Ensembl Gene ENSMUSG00000022414
Gene Name TGF-beta activated kinase 1/MAP3K7 binding protein 1
Synonyms 2310012M03Rik, Map3k7ip1, b2b449Clo, Tak1-binding protein 1
MMRRC Submission 038372-MU
Accession Numbers
Essential gene? Essential (E-score: 1.000) question?
Stock # R0085 (G1)
Quality Score 225
Status Validated
Chromosome 15
Chromosomal Location 80017333-80045908 bp(+) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) G to T at 80040094 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Alanine to Serine at position 305 (A305S)
Ref Sequence ENSEMBL: ENSMUSP00000023050 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000023050]
AlphaFold Q8CF89
PDB Structure Structural basis of autoactivation of p38 alpha induced by TAB1 (Monoclinic crystal form) [X-RAY DIFFRACTION]
Structural basis of autoactivation of p38 alpha induced by TAB1 (Tetragonal crystal form) [X-RAY DIFFRACTION]
Structural basis of autoactivation of p38 alpha induced by TAB1 (Tetragonal crystal form with bound sulphate) [X-RAY DIFFRACTION]
Predicted Effect probably benign
Transcript: ENSMUST00000023050
AA Change: A305S

PolyPhen 2 Score 0.005 (Sensitivity: 0.97; Specificity: 0.74)
SMART Domains Protein: ENSMUSP00000023050
Gene: ENSMUSG00000022414
AA Change: A305S

DomainStartEndE-ValueType
PP2Cc 26 363 7.45e-40 SMART
low complexity region 397 408 N/A INTRINSIC
low complexity region 438 455 N/A INTRINSIC
PDB:4L3P|A 466 502 6e-17 PDB
Meta Mutation Damage Score 0.1885 question?
Coding Region Coverage
  • 1x: 99.0%
  • 3x: 98.1%
  • 10x: 95.6%
  • 20x: 90.4%
Validation Efficiency 95% (71/75)
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] The protein encoded by this gene was identified as a regulator of the MAP kinase kinase kinase MAP3K7/TAK1, which is known to mediate various intracellular signaling pathways, such as those induced by TGF beta, interleukin 1, and WNT-1. This protein interacts and thus activates TAK1 kinase. It has been shown that the C-terminal portion of this protein is sufficient for binding and activation of TAK1, while a portion of the N-terminus acts as a dominant-negative inhibitor of TGF beta, suggesting that this protein may function as a mediator between TGF beta receptors and TAK1. This protein can also interact with and activate the mitogen-activated protein kinase 14 (MAPK14/p38alpha), and thus represents an alternative activation pathway, in addition to the MAPKK pathways, which contributes to the biological responses of MAPK14 to various stimuli. Alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]
PHENOTYPE: Homozygous mutant fetuses exhibit edema, hemorrhaging, cardiovascular and pulmonary dysmorphogenesis, and die in the late stages of gestation. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 50 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Acad12 A G 5: 121,742,357 (GRCm39) I417T possibly damaging Het
Adcy9 T C 16: 4,106,088 (GRCm39) T1009A probably benign Het
Ass1 A T 2: 31,404,831 (GRCm39) N371Y probably damaging Het
Baat T C 4: 49,490,425 (GRCm39) probably benign Het
Bpi T A 2: 158,115,072 (GRCm39) L311* probably null Het
Brd2 A C 17: 34,332,233 (GRCm39) F294L probably damaging Het
Carmil1 T A 13: 24,209,850 (GRCm39) E804D probably benign Het
Cd209g A T 8: 4,184,785 (GRCm39) probably benign Het
Cfi A G 3: 129,668,635 (GRCm39) I554V probably benign Het
Clvs2 G C 10: 33,498,542 (GRCm39) S129R possibly damaging Het
Dst T C 1: 34,268,268 (GRCm39) S2897P probably damaging Het
Efcab7 T C 4: 99,761,877 (GRCm39) probably benign Het
Fbxo2 T C 4: 148,249,367 (GRCm39) probably null Het
Fgfr2 C A 7: 129,797,993 (GRCm39) R400L probably damaging Het
Hsd17b14 T C 7: 45,205,834 (GRCm39) probably benign Het
Il23r T C 6: 67,463,206 (GRCm39) N96D probably damaging Het
Ints13 T A 6: 146,476,285 (GRCm39) probably benign Het
Khdc4 T A 3: 88,619,046 (GRCm39) S583R probably damaging Het
Lig1 A G 7: 13,041,495 (GRCm39) I776V possibly damaging Het
Madd T C 2: 90,993,083 (GRCm39) I997V probably benign Het
Mgat4b C T 11: 50,121,826 (GRCm39) H116Y possibly damaging Het
Myh11 C A 16: 14,041,883 (GRCm39) Q720H probably damaging Het
Myo5b A C 18: 74,834,751 (GRCm39) D937A probably benign Het
Nox3 T C 17: 3,685,556 (GRCm39) N584S probably benign Het
Ogfr A G 2: 180,232,830 (GRCm39) probably null Het
Or11g25 T A 14: 50,723,791 (GRCm39) M292K probably benign Het
Or13p3 T C 4: 118,567,078 (GRCm39) V158A probably benign Het
Or8b1b T C 9: 38,375,958 (GRCm39) I207T probably benign Het
Osbpl6 G T 2: 76,423,758 (GRCm39) V728F probably benign Het
Picalm T A 7: 89,831,525 (GRCm39) S453T probably benign Het
Piezo1 A G 8: 123,228,354 (GRCm39) L310P probably damaging Het
Pitrm1 C T 13: 6,599,604 (GRCm39) probably benign Het
Pkd1 T C 17: 24,805,197 (GRCm39) F3250L probably damaging Het
Plekha4 C T 7: 45,193,373 (GRCm39) R376* probably null Het
Pnma8b A T 7: 16,679,474 (GRCm39) S153C unknown Het
Rp1l1 C T 14: 64,259,744 (GRCm39) R129W probably damaging Het
Ryr3 A G 2: 112,690,108 (GRCm39) V1147A probably damaging Het
Sema3d G A 5: 12,620,953 (GRCm39) V520I probably benign Het
Sgsm1 A G 5: 113,427,136 (GRCm39) probably benign Het
Slc13a2 A G 11: 78,297,694 (GRCm39) V58A probably damaging Het
Slc1a4 A G 11: 20,254,510 (GRCm39) probably benign Het
Slc4a10 G A 2: 62,074,690 (GRCm39) probably benign Het
Tmem30a T A 9: 79,678,576 (GRCm39) T327S probably benign Het
Tpr A C 1: 150,293,164 (GRCm39) E863A possibly damaging Het
Upk3bl A G 5: 136,088,969 (GRCm39) N161D probably benign Het
Ush1c T A 7: 45,874,979 (GRCm39) I131F probably benign Het
Wdfy4 C A 14: 32,800,200 (GRCm39) R1975S possibly damaging Het
Zbtb18 C T 1: 177,275,501 (GRCm39) A287V probably benign Het
Zfp712 T C 13: 67,189,256 (GRCm39) T424A probably benign Het
Zfp791 G T 8: 85,838,862 (GRCm39) Y56* probably null Het
Other mutations in Tab1
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL02686:Tab1 APN 15 80,033,031 (GRCm39) missense probably benign 0.05
memento UTSW 15 80,037,869 (GRCm39) missense probably damaging 0.96
Memoir UTSW 15 80,037,941 (GRCm39) missense probably damaging 1.00
R1341:Tab1 UTSW 15 80,044,315 (GRCm39) missense possibly damaging 0.86
R1835:Tab1 UTSW 15 80,032,497 (GRCm39) missense probably benign 0.42
R1907:Tab1 UTSW 15 80,037,869 (GRCm39) missense probably damaging 0.96
R3113:Tab1 UTSW 15 80,032,461 (GRCm39) missense probably benign 0.23
R3943:Tab1 UTSW 15 80,037,941 (GRCm39) missense probably damaging 1.00
R3944:Tab1 UTSW 15 80,037,941 (GRCm39) missense probably damaging 1.00
R4845:Tab1 UTSW 15 80,036,964 (GRCm39) missense probably damaging 1.00
R5345:Tab1 UTSW 15 80,034,014 (GRCm39) missense possibly damaging 0.48
R5696:Tab1 UTSW 15 80,032,930 (GRCm39) nonsense probably null
R6223:Tab1 UTSW 15 80,032,464 (GRCm39) missense probably damaging 1.00
R6242:Tab1 UTSW 15 80,039,971 (GRCm39) nonsense probably null
R6561:Tab1 UTSW 15 80,033,031 (GRCm39) missense probably benign 0.05
R7239:Tab1 UTSW 15 80,017,372 (GRCm39) missense probably benign 0.15
R7422:Tab1 UTSW 15 80,044,445 (GRCm39) missense probably benign 0.00
R7810:Tab1 UTSW 15 80,042,999 (GRCm39) missense possibly damaging 0.86
R7922:Tab1 UTSW 15 80,043,066 (GRCm39) missense possibly damaging 0.52
R7951:Tab1 UTSW 15 80,043,058 (GRCm39) missense probably damaging 0.98
R8007:Tab1 UTSW 15 80,042,969 (GRCm39) missense possibly damaging 0.94
R8037:Tab1 UTSW 15 80,044,471 (GRCm39) missense probably benign 0.08
R8038:Tab1 UTSW 15 80,044,471 (GRCm39) missense probably benign 0.08
R9221:Tab1 UTSW 15 80,034,754 (GRCm39) missense probably benign 0.00
R9273:Tab1 UTSW 15 80,041,904 (GRCm39) missense probably benign 0.00
R9590:Tab1 UTSW 15 80,040,097 (GRCm39) missense probably damaging 0.97
R9762:Tab1 UTSW 15 80,032,943 (GRCm39) missense probably damaging 0.96
Predicted Primers PCR Primer
(F):5'- TCTCACCTCAGCAGAAGCAGTGAC -3'
(R):5'- TCCAGCAGTCTCAGTAGGCAGAAC -3'

Sequencing Primer
(F):5'- GGGGTCTTTTTCCACACAAAGC -3'
(R):5'- GGAAGAGTTGTATCCTCCCCATAATC -3'
Posted On 2013-04-11